Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3356

Actual shortage: 218 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3128 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

62 (26%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2022-09-01 2022-09-23 168424
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2024-06-20 2024-11-22 231027
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2024-07-25 2024-11-22 233709
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2024-08-15 2025-02-07 235342
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2024-12-19 2025-01-17 246056
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2023-07-13 2023-12-22 198505
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2023-10-27 2024-02-09 208411
APO-PERINDOPRIL-INDAPAMIDE 1.25MG 4MG TABLET Resolved 2023-02-09 2023-09-22 184092
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Avoided shortage 2023-03-09 2023-09-15 186580
APO-PERINDOPRIL-INDAPAMIDE 8MG 2.5MG TABLET Resolved 2023-03-09 2023-09-22 186583
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-06-02 2023-06-29 193617
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2024-04-05 2024-04-19 224586
APO-PERINDOPRIL/AMLODIPINE 7MG 5MG TABLET Resolved 2020-04-22 2020-04-28 112741
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-09-15 2023-09-28 204424
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-10-20 2023-10-27 207704
APO-PERINDOPRIL/AMLODIPINE 5MG 7MG TABLET Resolved 2023-10-20 2023-10-27 207707
APO-PERINDOPRIL/AMLODIPINE 10MG 14MG TABLET Resolved 2023-11-10 2024-02-09 209936
APO-PERINDOPRIL/AMLODIPINE 5MG 7MG TABLET Resolved 2023-11-24 2023-12-15 211490
APO-PERINDOPRIL/AMLODIPINE 2.5MG 3.5MG TABLET Resolved 2023-12-01 2023-12-15 212386
APO-PERINDOPRIL/AMLODIPINE 14MG 10MG TABLET Resolved 2020-08-19 2020-09-25 122486

Showing 2301 to 2320 of 3356

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-10 2018-12-28 60997
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-METOPROLOL 25MG TABLET To be discontinued 2018-09-07 2021-06-03 60628
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-MYCOPHENOLATE 500MG TABLET Discontinued 2018-09-07 2018-10-12 60640
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NAPRO-NA DS 550MG TABLET Discontinued 2018-09-08 2018-09-15 60660
APO-NAPROXEN 250MG TABLET Discontinued 2018-09-08 2018-09-15 60666
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257

Showing 221 to 240 of 359